S&P revises Hackensack University Medical Center’s outlook to positive

S&P has upgraded Hackensack (N.J.) University Medical Center’s outlook to positive from stable and affirmed the hospital’s “A-” long-term rating and “A-” underlying rating.

Advertisement

“We revised the outlook to positive based on HackensackUMC’s material improvement in cash flow,” said Cynthia Keller, an S&P analyst. The credit rating agency also considered the hospital’s definitive agreement to merge with Neptune, N.J.-based Meridian Health System. “We assessed HackensackUMC’s enterprise profile as very strong,” said Ms. Keller.

The rating affirmation was based on several factors, including the hospital’s leading market share and active participation in a number of joint ventures and affiliations.

More articles on healthcare finance:

CMS proposes changes to Physician Fee Schedule: 15 things to know
45 states earn ‘F’ grades for healthcare price transparency
Why CFO roles are being filled by Gen Xers

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.